| 000 | 00461nam a22001337a 4500 | ||
|---|---|---|---|
| 008 | 250415b |||||||| |||| 00| 0 eng d | ||
| 082 | _aWIN/2025/FIN-SPE/PR6728 | ||
| 245 |
_aA Study on the Risk Return Evaluation of Pharmaceutical Sector Companies _cTanvi Pednekar |
||
| 260 |
_aMumbai _bSFIMAR _cWIN/2025 |
||
| 650 | _aFIN-SPE | ||
| 654 | _aA Study on the Risk Return Evaluation of Pharmaceutical Sector Companies | ||
| 720 | _aProf. Jinal Lathia | ||
| 942 | _cPR | ||
| 999 |
_c40845 _d40845 |
||